Skip to main content

Reporter

Exercise fights fatty liver

Nov. 18, 2011—Fatty liver, a reversible condition of fat accumulation in liver cells, can result from excessive alcohol consumption, obesity, type 2 diabetes, or metabolic disorders. Exercise can reverse this process, but the mechanisms underlying this effect are not clear. Because exercise is known to stimulate the action of glucagon (a hormone that raises blood glucose levels)...

Read more


Skeletal defects in genetic disorder

Nov. 18, 2011—A new mouse model provides a tool for testing novel therapeutic approaches for neurofibromatosis.

Read more


Averting a future oncologist shortage

Nov. 11, 2011—Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists.

Read more


Balancing act in the gut

Nov. 11, 2011—Vanderbilt researchers have identified an antigen important to balancing the immune response to bacteria in the gut.

Read more


Breastfeeding problems can be linked to a tied tongue

Nov. 10, 2011—A simple procedure can correct ‘tongue-tie,’ a commonly missed condition that could prevent newborns from breastfeeding properly.

Read more


Let there be light and melatonin

Nov. 4, 2011—Light and the hormone melatonin may play important roles in the developing brain.

Read more


Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


Lung disorder drug regimen found harmful

Oct. 31, 2011—Longtime treatment for IPF ineffective and even dangerous.

Read more


Protein family key to aging linked to suppressing tumors

Oct. 28, 2011—The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.

Read more


Vanderbilt doctors to screen patients taking statins for genetic risk factors

Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

Read more


Stopping colitis, STAT

Oct. 27, 2011—Study suggests a new therapeutic target in ulcerative colitis.

Read more


Growth factor boosts beta cells

Oct. 21, 2011—A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.

Read more


Page 442 of 443« First...436437438439440441442443

Recent Stories from VUMC News and Communications Publications

Our amazing skin

Vanderbilt Medicine

Our amazing skin

Biology and the beat

Vanderbilt Medicine

Biology and the beat

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

more